By V. Ben. Georgetown University.

Iis therefore importanto identify the situations where this cagory have been used as an excuse for refusing treatment cialis 20 mg without prescription, which in reality involve a problem in the priorities of life generic 20 mg cialis otc. This cagory includes the patients with ethical/moral or religious values safe cialis 20mg, for whom their own health and its treatmenare a matr of high priority 2.5mg cialis sale, buwho find certain treatmenmethods unacceptable. An example of this mighbe Jehovah�s Witnesses, who refuse blood transfusion (Gyamfi eal 2003). Ihas also been repord thapork- and beef-derived gelatin and/or saric acid, which are used as inercomponents in some drugs, are unacceptable to some patients in the Muslim, Orthodox Christian, and Seventh Day Adventisfaiths (Sattar eal 2004). In birth control some people cannoaccepmethods thahave postfertilization effects, such as intraurine devices, hormonal emergency contraception and oral contraceptives (Larimore 2000, Larimore and Stanford 2000, Kahlenborn eal 2002, Stanford and Mikolajczyk 2002). Ihas been found in Finland that, of several therapeutic classes gynecological patients (the main subgroup was oral contraceptives) received leascounseling from pharmacists (Vainio eal 2002). Furthermore, future embryonic sm cell treatments are considered non- acceptable for those patients who find thaa patient�s sickness should nobe healed with a method tharequires the life of a human embryo to be destroyed. If these ethical/moral or religious values are combined with the patient�s view thahealth is noa high-priority matr, the case does nobelong to this cagory, buto the priorities of life cagory. For example, if the day of death is unchangeable, actions to improve one�s health mighseem unnecessary. However, this view conflicts with all findings of modern medicine showing thaa group of patients taking a certain medicine survive longer than another group of patients taking placebo. And even if the day of death is unchangeable, from a patient�s view, is the quality of life unchangeable? Preventing a hearattack or stroke n years before death mighbe very beneficial for the quality of life. Between inntional and non-inntional non-compliance and non-concordance Inntional and non-inntional non-compliance can also be partly simultaneous. If the taking of medicines is noso important, other things fill up the mind, and iis easy to forgeto take the medicine (Barber 2002). Simultaneous memory problems in inntional non-compliance and non-concordance may be more like secondary memory problems, which are noreal memory problems. To clarify this possibility, the patienwith memory problems should be asked abouthe attitudes and opinions of the perceived importance of medication-taking. However, the reliability of inrview-based self-reports has been found to be problematic (Garber ea2004), and future studies need to find more suitable chniques for inrviews or e. Clarification of the main reason for non-compliance/non- concordance is importanboth in medical practice and in research. However, in research iis a pontial source of bias if patients with inntional behaviour and memory problems are misclassified in both groups in statistical analyses. Motivation The connection between motivation and compliance and concordance is inresting and involves elements thaare relad to differentypes of non-compliance and non- concordance. If life is depressing, the patienmay lack motivation for many things, including medication-taking and this probably belongs to the disease cagory. If the priorities of life are noin order, there mighnobe motivation to take medication, i. Iis also possible thahealth care professionals do nomotiva patients enough, and the patiendoes nounderstand the importance of antihypernsive medication and has individualistic ways of taking care of his/her health by using his/her own methods and partly or complely neglects the medical regimen. Applications of the classificatory model The classification of non-compliance and non-concordance helps us to understand the complex phenomena of compliance and concordance, which is essential for achieving progress in research. Although the understanding of non-compliance/non-concordance is essential, imusbe borne in mind thathere are also other reasons for failure in treatment. An example of this could be a study on resistanhypernsion patients, for whom the reason was found in 91% of the cases (Yakovlevitch and Black 1991). The moscommon reasons for resistanhypernsion were: inadequa dosage or failure to prescribe antihypernsive drugs according to indication (43%), intolerable adverse drug effects despi several atmpts with differendrugs (half of the cases were also associad with non-compliance) (14%), secondary hypernsion (11%), non- compliance (10%), misinrpretation of psychological or physical signals as adverse drug effects of antihypernsive drugs (8%). In their study, 53% of patients had their blood pressure in control and the situation was clearly improved in another 11% of patients. Profound understanding of non-compliance/non-concordance combined with effective and adequa treatments is needed for success in medical practice. The classificatory model sheds lighon both the compliance and concordance theories, offering a possibility to develop methods of measurementhatake into accounthe classification of phenomenona which should be considered an essential parof any seriously taken method of measurement. Patient-perceived problems concern practically every patienwith antihypernsive drug therapy in Finnish primary health care. Inntional non-compliance with antihypernsive medication is associad with patient-perceived problems in the areas of everyday life relad problems, health care sysm relad problems and patient-relad problems. Poor control of blood pressure with antihypernsive drug therapy is associad with patient-perceived everyday life-relad problems, hopeless attitude towards hypernsion and frustration with treatment. The association between blood pressure control and compliance was problematic to establish. The classifying model of non-compliance and non-concordance, which was cread, cagorizes the complex phenomenon into several entities and helps in understanding non-compliance. The hypernsion-relad findings of this study show thathe treatmenof hypernsive patients in Finland is far from optimal. The sysm of health care has many importantargets, especially in the areas associad with non-compliance or poor outcome of treatment. These targets include reorganization of patienservices as more patient-friendly, change of attitudes among health care professionals into a more supportive direction and developmenof ways to share more effective and tailored individualistic information. Both amwork between health care professionals and education abouthe health care professional-patienrelationship is needed to achieve betr understanding of patients� ways of thinking and, correspondingly, to educa the patienbetr abouhealth-relad information. The follow-up of hypernsive as well as other chronic patients should be arranged properly. This type of developmennaturally requires more resources, buthese resources of our health care should also be used more effectively. The findings of this study relad to the compliance theory are challenging to both compliance and concordance research. First, by dividing non-compliance into nine differensub-phenomena, which help us to understand this complex phenomenon more profoundly. Second, they challenge future research to study each of these phenomenona so thabetr treatmenoutcomes could be achieved in medical practice. Patrns of hypernsion managemenin Italy: results of a pharmacoepidemiological survey on antihypernsive therapy. Relationship between home blood pressure measuremenand medication compliance and name recognition of antihypernsive drugs. Risk factors for antihypernsive medication refill failure by patients under Medicaid managed care. Compliance with antihypernsive treatmenin consultation rooms for hypernsive patients. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. Electronic compliance monitoring in resistanhypernsion: the basis for rational therapeutic decisions. Validation of patienreports, automad pharmacy records, and pill counts with electronic monitoring of adherence to antihypernsive therapy. A cohorstudy of possible risk factors for over-reporting of antihypernsive adherence.

In Australia buy discount cialis 10mg on line, Canada generic cialis 10mg free shipping, the Netherlands discount cialis 2.5mg fast delivery, other countries purchase cialis 2.5mg fast delivery, though in the former of these two group- New Zealand, and the U. In the Exhibit 3 shows that Americans with one chronic United States and Germany, however, there was little dif- illness or none were more likely to fill one or more pre- ference between those with below-average income and scriptions than were persons of similar health status in those with average income. Resulting patient requests for prescriptions Americans may be receiving more medicines than they 4 The Commonwealth Fund Exhibit 4. Percent of Population Reporting Use of One or More financial Barriers and Prescription Prescription Drugs During the Previous 12 Months, Drug-Skipping by Country and Income Reported rates of cost-related nonadherence to prescribed All incomes Below-average income treatments add further evidence of inequity in access to Average income Above-average income Percent prescription drugs in the U. With or without adjusting for sex, age, income, income were far more likely than those with above- and health status, residents of all other countries studied average income to rate their health as fair or poor (31% were significantly less likely (50 percent or more) than vs. High- incomes in four of the survey countries have higher rates income Americans were as or more likely to report cost- of use than in this the U. Percent of Population Reporting Not Filling a Prescription or Skipping a Dose Because of Cost During the Previous 12 Months Unadjusted odds ratio Adjusted odds ratio Country rates (95% confdence interval) (95% confdence interval) United States 23. Prescription Drug Accessibility and Affordability in the United States and Abroad 5 Exhibit 6. Average income Above-average income Percent 50 out-of-Pocket Costs 40 Even with their higher rate of unfulfilled prescriptions, 30 Americans are much more likely than residents of the 20 other countries to report out-of-pocket spending in excess of $1,000 in the previous year. The next highest share of population paying $1,000 or more in out-of-pocket for prescription combined in every country except Australia. This likely reflects gaps in cover- In countries with comprehensive drug benefit age and high cost-sharing that even insured Americans programs that have low copayments—Germany, the often experience. Studies repeatedly find negative national differences in drug prices because standard health and total cost effects from high out-of-pocket pre- doses and package sizes vary from country to country scription costs for patients with chronic disease and other and are seldom taken into account in price comparisons. In other countries, a focus on health secure savings has the effect of driving up the list prices and drug benefit policy designed to provide universal of drugs, there is little doubt that uninsured persons in access to essential treatments works together with group the U. Thus, cross-national dif- Affordability of medicines for individual patients is ferences in drug spending likely result from the combined facilitated by policies that limit cost-sharing for covered effects of higher use of medicines in the U. Most of these countries do so with relatively low cost-sharing by Prescription Drug Accessibility and Affordability in the United States and Abroad 7 patients, especially for vulnerable populations (e. Such comparative assessment review can help spur Canadian system of public drug coverage is comparable both the development and adoption of innovative and to that of the U. However, public programs for coverage under a universal drug benefit system, a finance a greater share of total prescription drug costs in key consideration is the price that can be charged. In Canada, prices are limited in com- to geography, age, income, or employment—can be parison to those charged in seven comparator countries cost-effective when viewed from health system and (including the U. Consider public benefits in and 2) relative pricing policies and negotiations concern- New Zealand, which operate with a national formulary ing the price of medicines. Different formularies may uses a variety of supplier contracts and coverage policies apply to different patients, depending upon their insurer. Zealand, per capita pharmaceutical spending in the Therefore, the National Institute for Health and Clinical U. In other countries, every medicine is appraised to implied by such a thought experiment is on the order 8 The Commonwealth Fund of $80 billion in 2005 alone. Because uninsured management occurs despite the fact that the underlying Americans are currently more likely than their insured health systems are based on social insurance models with counterparts to go without prescribed medications, this 13 many competing insurers. One message from mation to guide and inform benefit designs and pricing abroad is clear: sustainability, affordability, and equity in policies can help moderate cost increases while assuring pharmaceutical coverage will require commitment to uni- access to effective medications, including new products. Interviews were conducted with 1,000 adults in Australia and in New Zealand; 1,500 adults in Germany, in the Netherlands, and in the United Kingdom; 2,500 adults in the United States; and 3,000 adults in Canada. In our analyses, we weighted individual responses to be representative of national populations. Where we report shares of populations providing specific answers to survey questions, we used chi-squared tests to determine whether there were statistically significant differences between countries and to determine whether there were statistically significant differences across age, income, and health status within countries. We report adjusted odds ratios that compare specific results across all countries, using the U. These models are adjusted for sex, age, income, and health status (number of chronic conditions reported). We com- pare accessibility results across specific subpopulations of working-age adults in the U. Prescription Drug Accessibility and Affordability in the United States and Abroad 9 8 Notes R. Copayment on Rational Drug Use,” Cochrane 3 Database of Systematic Reviews: Reviews, Jan. Ross-Degnan, “The Case for a Medicare Policy Systems: A ‘Triple-A’ Framework and Example Drug Coverage Benefit: A Critical Review of the Analysis,” The Open Health Services and Policy Journal, Empirical Evidence,” Annual Review of Public 2009 2(1):1–9; J. Goetzel, “The Effects of States and Canada: A System-Level Comparison Prescription Drug Cost Sharing: A Review of the Using the 2007 International Health Policy Survey Evidence,” American Journal of Managed Care, in Seven Countries,” Clinical Therapeutics, Jan. Berkman, “Social Epidemiology: Social Prescription Drugs: Coverage, Cost-Sharing, and Determinants of Health in the United States: Are We Financial Protection in Six European Countries Losing Ground? Descriptions of health care systems: Australia, Canada, Denmark, England, France, Germany, Italy, 12 S. Mitton, the Netherlands, New Zealand, Norway, Sweden, “Centralising Drug Review to Improve Coverage Switzerland, and the United States (New York: The Decisions: Economic Lessons from (and for) Commonwealth Fund, forthcoming). Mintzes, “Outcomes-Based Drug Coverage in British Columbia,” Health Affairs, May/June 2004 23(3):269–76. Health Reform from the German and Dutch Multipayer Systems (New York: The Commonwealth Fund, Dec. Morgan, “Cost-Related Prescription Nonadherence in the United States and Canada: A System-Level Comparison Using the 2007 International Health Policy Survey in Seven Countries,” Clinical Therapeutics, Jan. Morgan, “A Cross-National Study of Prescription Nonadherance Due to Cost: Data from the Joint Canada –U. Murukutla, “Toward Higher- Performance Health Systems: Adults’ Health Care Experiences in Seven Countries, 2007,” Health Affairs Web Exclusive, Oct. His work combines quantitative health services research with comparative policy analysis to help identify policies that achieve balance between three sometimes-competing goals: providing equitable access to necessary care, managing health expenditures, and promoting valued innova- tion. Morgan earned degrees in economics from the University of Western Ontario, Queen’s University, and the University of British Columbia; and received postdoctoral training at McMaster University. He is a recipient of career awards from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research, an alumnus of Harkness Fellowships in Health Care Policy, and a former Labelle Lecturer in Health Services Research. He worked as a research associate at the World Institute on Disability before he received his doctorate in health services and policy analysis at the University of California, Berkeley, in 1996. Kennedy’s research focuses primarily on access barriers to prescription medicines, medical care, rehabilitation, and long-term services, with particular emphasis on at-risk groups, including persons with disabilities, older adults, and the uninsured. Aminosalicylates can be used in Crohn’s disease or ulcerative colitis, however they are often more effective in ulcerative colitis. Aminosalicylates have been shown to independently induce and maintain remission in mild to moderate ulcerative colitis.

Prosocial involvement and antisocial peer afliations as predictors of behavior problems in urban adolescents: Main effects and moderating effects generic 2.5mg cialis visa. Cleaning up their act: The effects of marriage and cohabitation on licit and illicit drug use purchase 20 mg cialis free shipping. The Seattle Social Development Project: Effects of the frst four years on protective factors and problem behaviors purchase 2.5 mg cialis with amex. Screening purchase cialis 10 mg mastercard, behavioral counseling, and referral in primary care to reduce alcohol misuse. Preventive interventions addressing underage drinking: State of the evidence and steps toward public health impact. Long-term effects of nurse home visitation on children’s criminal and antisocial behavior: 15-year follow-up of a randomized controlled trial. Enduring effects of prenatal and infancy home visiting by nurses on children: follow-up of a randomized trial among children at age 12 years. The impact of the Good Behavior Game, a universal classroom-based preventive intervention in frst and second grades, on high-risk sexual behaviors and drug abuse and dependence disorders into young adulthood. The evaluation of two frst-grade preventive interventions on childhood aggression and adolescent marijuana use: A latent transition longitudinal mixture model. Adolescent substance use outcomes in the Raising Healthy Children project: A two-part latent growth curve analysis. Preventing youth violence and delinquency through a universal school-based prevention approach. Early results from a school alcohol harm minimization study: The School Health and Alcohol Harm Reduction Project. Benefts of universal intervention effects on a youth protective shield 10 years after baseline. Effects of family risk factors on dosage and efcacy of a family-centered preventive intervention for rural African Americans. Universal intervention effects on substance use among young adults mediated by delayed adolescent substance initiation. Long-term effects of universal preventive interventions on methamphetamine use among adolescents. Longitudinal effects of universal preventive intervention on prescription drug misuse: Three randomized controlled trials with late adolescents and young adults. Preventing escalation in problem behaviors with high-risk young adolescents: Immediate and 1-year outcomes. Substance use and delinquency among middle school girls in foster care: A three-year follow-up of a randomized controlled trial. Brief, personality-targeted coping skills interventions and survival as a non–drug user over a 2-year period during adolescence. Long-term effects of a personality- targeted intervention to reduce alcohol use in adolescents. Preventing substance use among adolescent girls: 1-year outcomes of a computerized, mother–daughter program. Reducing the risks of alcohol use among urban youth: Three-year effects of a computer-based intervention with and without parent involvement. Brief alcohol interventions for adolescents and young adults: A systematic review and meta-analysis. Identifcation, prevention, and treatment revisited: Individual-focused college drinking prevention strategies 1999–2006. Individual-level interventions to reduce college student drinking: A 1557 meta-analytic review. Screening and brief interventions for alcohol use in college health centers: A review. Face-to-face versus computer-delivered alcohol interventions for college drinkers: A meta-analytic review, 1998 to 2010. Defning and characterizing differences in college alcohol intervention efcacy: A growth mixture modeling application. Indicated prevention for college student marijuana use: A randomized controlled trial. Single-session alcohol interventions for heavy drinking college students: A systematic review and meta-analysis. Efcacy of expectancy challenge interventions to reduce college student drinking: A meta-analytic review. Brief motivational interventions for college student drinking may not be as powerful as we think: An individual participant‐level data meta‐analysis. Brief motivational and parent interventions for college students: A randomized factorial study. Efcacy of alcohol interventions for frst-year college students: A meta-analytic review of randomized controlled trials. A randomized clinical trial evaluating a combined alcohol intervention for high-risk college students. Evaluating the effects of a brief motivational intervention for injured drinkers in the emergency department. Prevention interventions of alcohol problems in the workplace: A review and guiding framework. The effectiveness of limiting alcohol outlet density as a means of reducing excessive alcohol consumption and alcohol-related harms. Case closed: Research evidence on the positive public health impact of the age 21 minimum legal drinking age in the United States. Youth problem behaviors 8 years after implementing the Communities That Care prevention system: A community-randomized trial. Sustained decreases in risk exposure and youth problem behaviors after installation of the Communities That Care prevention system in a randomized trial. Enhanced enforcement of laws prohibiting sale of alcohol to minors: Systematic review of effectiveness for reducing sales and underage drinking. The state sets the rate: The relationship among state-specifc college binge drinking, state binge drinking rates, and selected state alcohol control policies. Youth drinking in the United States: Relationships with alcohol policies and adult drinking. Evidence for the effectiveness and cost-effectiveness of interventions to reduce alcohol-related harm. The affordability of alcoholic beverages in the European Union: Understanding the link between alcohol affordability, consumption and harms. Effects of alcohol tax and price policies on morbidity and mortality: A systematic review.

Isolation of nontuberculous mycobacteria in the lomatous infectious diseases associated with tumor necrosis factor United States cialis 5mg visa. Performance stan- mycobacterial diseases in the United States: results from a national dards for antimicrobial susceptibility testing cheap cialis 10 mg overnight delivery. The epidemiology of disseminated nontu- testing of mycobacteria 2.5mg cialis with visa, nocardiae cheap cialis 20mg on-line, and other aerobic actinomycetes. Am J Society for Microbiology General Meeting, May 16, 1993, Atlanta, Respir Crit Care Med 1995;152:1570–1574. Nontuberculous mycobac- of mycobacteria from respiratory secretions of patients with cystic teria reported to the public health laboratory information system by fibrosis. Interferon-gamma and interleukin-12 pathway Manual of clinicalmicrobiology, 8th ed. Sensi- osis: thoracic anomalies associated with pulmonary disease caused tivity of fluorochrome microscopy for detection of Mycobacterium by Mycobacterium avium complex. Medicine (Baltimore) of Mycobacterium tuberculosis and Mycobacterium avium complex 1994;73:103. Rapidly growing mycobacterial cultures by high-performance liquid chromatography with fluores- lung infection in association with esophageal disorders. Mycolic acid analysis by high performance disease caused by rapidly growing mycobacteria: an analysis of 154 liquid chromatography for identification of Mycobacterium species. Pulmonary nontuberculous mycobacterium infections are highly with the AccuProbe Mycobacterium tuberculosis complex assay. Differentiation of slowly growing Mycobacterium type, and treatment responsiveness. Kirschner P, Springer B, Vogel U, Meier A, Wrede A, Kiekenbeck M, Microbiol 1995;33:2670–2674. Microaer- nucleic acid sequence determination: report of a 2 year experience ophilic conditions promote growth of Mycobacterium genavense. Nosocomial outbreak Successful treatment of refractory disseminated Mycobacterium of respiratory tract colonization with Mycobacterium fortuitum: dem- avium complex infection with the addition of linezolid and meflo- onstration of the usefulness of pulsed-field electrophoresis in an epi- quine. Epidemiology of infection by nontuberculous mycobac- containing regimens for disease caused by rifampin-resistant teria. Activities of clarithromycin against radiological appearances with pulmonary tuberculosis. Thorax 1996; eight slowly growing species of nontuberculous mycobacteria, deter- 51:1243–1247. Nontuberculous testing of Mycobacterium abscessus, Mycobacterium chelonae, and mycobacterial pulmonary infection in immunocompetent patients: Mycobacterium fortuitum. Diagnosis of disease caused by Mycobacterium avium of intrinsic macrolide resistance in clinical isolates of Mycobacterium complex. Intrinsic macrolide resistance in Mycobacterium smegmatis Ono N, Rikimaru T, Aizawa H. AntimicrobAgentsChemo- for the diagnosis of pulmonary disease caused by Mycobacterium ther 2003;47:3053–3060. Pulmonary disease caused by avium sensitin and purified protein derivative to discriminate pulmo- Mycobacterium chelonae in a heart-lung transplant recipient with nary disease due to Mycobacterium avium complex from pulmonary obliterative bronchiolitis. Infectious complications of lous mycobacteria: defining disease in a prospective cohort of South lung transplantation: impact of cystic fibrosis. Mycobacterialinfectionsinlungtransplantrecipi- terium avium complex in the respiratory or gastrointestinal tract and ents. Mycobac- Pulmonary illness associated with exposure to Mycobacterium avium terium abscessus and children with cystic fibrosis. Mycobacterial isolations in associated with exposure to metalworking fluid aerosols. Nontuberculous mycobac- rium abscessus and associated with clinical disease, pseudo-outbreaks teria in adult patients with cystic fibrosis. The Industrial Metal working Environment: Assessment cystic fibrosis: a prospective study. Am J Respir Crit Care ity of human and environmental isolates of Mycobacterium avium, Med 2000;161:641–645. Antimicrob Agents Chemother patients with cystic fibrosis chronically infected with Pseudomonas 1984;25:137–139. Therapeuticdrugmonitoring cause of hypersensitivity pneumonitis in machine workers. Results of operation in sensitivity pneumonitis in automobile production workers exposed Mycobacterium avium-intracellulare lung disease. Mycobacterial infections in renal ers exposed to metalworking fluid contaminated with nontuberculous transplant recipients: report of five cases and review of the literature. High chelonae: a cause of nodular skin lesions with a proclivity for renal rates of infection and colonization by nontuberculous mycobacteria transplant recipients. Infections due to nontu- corticosteroid therapy, frequency of disseminated infections, and re- berculous mycobacteria in kidney, heart and liver transplant recipi- sistance to oral antimicrobials other than clarithromycin. Mycobacterial infection in a series of 1261 renal transplant Disseminatedinfectionwithrapidlygrowingmycobacteria. J Heart Disseminatedinfection dueto rapidlygrowingmycobacteria inimmu- Transplant 1990;9:357–363. Mycobacterial lymphadenitis in children: a prospective in a patient infected with human immunodeficiency virus. CervicofaciallympadenitisinchildrencausedbyMyco- rium chelonae keratitis cases following laser in-situ keratomileusis. Localized soft tissue infections with Mycobacterium Infection with Mycobacterium malmoense in Sweden: report of 221 avium, Mycobacterium intracellulare complex in immunocompetent cases. Bacteriologically confirmed non- species after blunt trauma to the back: three examples of the principle tuberculous mycobacterial lymphadenitis in southeast England: a re- of locus minoris resistentia. Mycobacterium absessus aspiration cytologic examination and tuberculin skin test in the diag- pseudoinfection traced to an automated endoscope washer: utility of nosis of cervical tuberculous lymphadenitis. Cytodiagnosis of Infections with Mycobacterium chelonei in patients receiving dialysis tuberculosis lymphadenitis. Mycobacterium chelonei endemy after heart surgery with fatal Abstr Gen Meet Am Soc Microbiol 1997;571. Mycobacterium of Mycobacterium fortuitum isolates from sternotomy wounds by absessus pseudoinfection traced to an automated endoscope washer: antimicrobial susceptibilities, plasmid profiles, and ribosomal ribo- utility of epidemiologic and laboratory investigation. IatrogenicoutbreakofMycobacterium Mycobacterium fortuitum complex: a potential environmental source. Mycobacterium chelonae wound infections after plastic Morb Mortal Wkly Rep 2004;53:192–194. J Infect Dis Peritonitis due to a Mycobacterium chelonae-like organism associated 1983;147:427–433.